| # | Title | Journal | Year | Citations |
|---|
| 1 | Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial | Lancet Oncology, The | 2019 | 97 |
| 2 | Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial | | 2020 | 85 |
| 3 | Evolution of the Experimental Models of Cholangiocarcinoma | Cancers | 2020 | 76 |
| 4 | Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts | ESMO Open | 2021 | 65 |
| 5 | Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy | British Journal of Cancer | 2014 | 53 |
| 6 | Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial | Lancet Oncology, The | 2020 | 51 |
| 7 | Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD | Blood | 2006 | 46 |
| 8 | Nivolumab plus low-dose ipilimumab as first-line therapy in microsatellite instability-high/DNA mismatch repair deficient metastatic colorectal cancer: Clinical update. | Journal of Clinical Oncology | 2020 | 46 |
| 9 | ZnO nanocrystals shuttled by extracellular vesicles as effective Trojan nano-horses against cancer cells | Nanomedicine | 2019 | 41 |
| 10 | CD44v6 as innovative sarcoma target for CAR-redirected CIK cells | OncoImmunology | 2018 | 38 |
| 11 | Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group | Frontiers in Oncology | 2020 | 38 |
| 12 | Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells | Clinical Cancer Research | 2017 | 34 |
| 13 | Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas | JAMA Oncology | 2020 | 33 |
| 14 | Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group | Cancer | 2021 | 30 |
| 15 | The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis | Oncologist | 2020 | 27 |
| 16 | Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG) | Annals of Surgical Oncology | 2021 | 26 |
| 17 | Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature | Cancer Medicine | 2021 | 23 |
| 18 | High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series | Cells | 2020 | 22 |
| 19 | Role of interferon in melanoma: old hopes and new perspectives | Expert Opinion on Biological Therapy | 2017 | 21 |
| 20 | Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine | Cancers | 2019 | 21 |
| 21 | Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG | Cancer | 2020 | 21 |
| 22 | Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors | European Radiology | 2021 | 20 |
| 23 | Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group | Cancer | 2020 | 19 |
| 24 | Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) | Annals of Surgical Oncology | 2021 | 19 |
| 25 | Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights | Cancers | 2020 | 15 |
| 26 | Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group | Cancers | 2021 | 15 |
| 27 | Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial | Cancer Immunology, Immunotherapy | 2021 | 15 |
| 28 | The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma | Liver International | 2022 | 15 |
| 29 | Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial | Journal of Clinical Oncology | 2022 | 15 |
| 30 | IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort. | Journal of Clinical Oncology | 2020 | 14 |
| 31 | Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group | Annals of Surgical Oncology | 2022 | 13 |
| 32 | Delving into PARP inhibition from bench to bedside and back | | 2020 | 11 |
| 33 | Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer? | Cancers | 2019 | 10 |
| 34 | Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma | Future Oncology | 2021 | 10 |
| 35 | Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study | ESMO Open | 2021 | 10 |
| 36 | Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-lnduced Killer Cells | Molecular Medicine | 2017 | 9 |
| 37 | Validation process of Toronto Exremity Salvage Score in Italian: A quality of life measure for patients with extremity bone and soft tissue tumors | Journal of Surgical Oncology | 2020 | 9 |
| 38 | Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures | Cancers | 2020 | 8 |
| 39 | A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient | Cancers | 2021 | 8 |
| 40 | Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East | International Journal of Cancer | 2021 | 8 |
| 41 | Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study | | 2022 | 8 |
| 42 | CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study | Cancer Medicine | 2023 | 7 |
| 43 | Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index | Journal of Gastrointestinal Cancer | 2022 | 6 |
| 44 | Enhancing Proteotoxic Stress in Leiomyosarcoma Cells Triggers Mitochondrial Dysfunctions, Cell Death, and Antitumor Activity in vivo | Molecular Cancer Therapeutics | 2021 | 6 |
| 45 | A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor | BMC Cancer | 2022 | 6 |
| 46 | Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network | Cancer | 2022 | 5 |
| 47 | Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients | Cancers | 2019 | 4 |
| 48 | ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) | Annals of Surgical Oncology | 2021 | 4 |
| 49 | Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients | BMC Cancer | 2021 | 4 |
| 50 | SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor | Frontiers in Oncology | 2021 | 4 |
